--- title: "HealthStream | 8-K: FY2025 Q2 Revenue Beats Estimate at USD 74.4 M" type: "news" locale: "en" url: "https://longbridge.com/en/news/251511825.md" published_at: "2025-08-04T20:36:06.000Z" --- # HealthStream | 8-K: FY2025 Q2 Revenue Beats Estimate at USD 74.4 M Revenue: As of FY2025 Q2, the actual value is USD 74.4 M, beating the estimate of USD 74.39 M. EPS: As of FY2025 Q2, the actual value is USD 0.18, beating the estimate of USD 0.156. EBIT: As of FY2025 Q2, the actual value is USD 6.867 M, beating the estimate of USD 5.391 M. ### Financial Metrics Summary #### Revenue - Total revenue for the second quarter of 2025 was $74.4 million, marking a 4.0% increase from $71.6 million in the second quarter of 2024. - Subscription revenues increased by $2.9 million, or 4.2%, while professional services revenues decreased by $0.1 million compared to the second quarter of 2024. - Revenues for the first six months of 2025 were $147.9 million, an increase of 2.5% over revenues of $144.3 million for the first six months of 2024. #### Operating Income - Operating income for the second quarter of 2025 was $5.9 million, up 33.4% from $4.4 million in the second quarter of 2024. - Operating income for the first six months of 2025 increased by 1.6% to $10.3 million, compared to $10.1 million for the first six months of 2024. #### Net Income - Net income for the second quarter of 2025 was $5.4 million, an increase of 29.3% from $4.2 million in the second quarter of 2024. - Net income for the first six months of 2025 increased to $9.7 million, compared to $9.4 million for the first six months of 2024. #### Adjusted EBITDA - Adjusted EBITDA for the second quarter of 2025 was $17.6 million, up 11.3% from $15.8 million in the second quarter of 2024. - Adjusted EBITDA increased by 2.8% to $33.8 million for the first six months of 2025, compared to $32.9 million for the first six months of 2024. #### Cash Flow - Net cash provided by operating activities for the six months ended June 30, 2025, was $32.1 million, compared to $27.4 million for the same period in 2024. - Net cash used in investing activities was - $18.4 million for the six months ended June 30, 2025. - Net cash used in financing activities was - $21.1 million for the six months ended June 30, 2025. ### Financial Outlook for 2025 - The Company projects full-year 2025 revenue to be between $297.5 million and $303.5 million. - Net income is expected to range from $19.5 million to $22.4 million. - Adjusted EBITDA is projected to be between $68.5 million and $72.5 million. - Capital expenditures are anticipated to be between $31.0 million and $34.0 million. ### Related Stocks - [HSTM.US - HealthStream](https://longbridge.com/en/quote/HSTM.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | HealthStream Inc. Files Initial Statement of Beneficial Ownership for Senior Vice President Jennifer Hayes LoPresto | HealthStream Inc. has filed an initial statement of beneficial ownership (Form 3) with the U.S. Securities and Exchange | [Link](https://longbridge.com/en/news/274659230.md) | | VP Cunningham Sells 2,100 ($50.6K) Of HealthStream Inc [HSTM] | Cunningham Jeff Vice President of HealthStream Inc [HSTM] filed a Form 4 on December 10, 2025 with the Securities and Ex | [Link](https://longbridge.com/en/news/269298781.md) | | Dir Taylor Tate Sells 1,580 ($40.2K) Of HealthStream Inc [HSTM] | Taylor Tate Deborah Director of HealthStream Inc [HSTM] filed a Form 4 on December 1, 2025 with the Securities and Excha | [Link](https://longbridge.com/en/news/268148967.md) | | HealthStream's (HSTM) "Hold" Rating Reiterated at Canaccord Genuity Group | Canaccord Genuity Group reaffirmed a "hold" rating for HealthStream (HSTM) with a $28.00 price target, indicating a pote | [Link](https://longbridge.com/en/news/270057537.md) | | HealthStream Acquires MissionCare Collective for Up to $40 Million | HealthStream has acquired MissionCare Collective, a healthcare workforce company, for up to $40 million. The acquisition | [Link](https://longbridge.com/en/news/269769294.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.